Swiss - Delayed Quote CHF

Molecular Partners AG (MOLN.SW)

3.0700
+0.0800
+(2.68%)
At close: 5:31:06 PM GMT+2
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,232
4,970
7,038
189,556
9,330
Operating Expense
63,733
66,187
68,146
72,943
72,749
Operating Income
-61,501
-61,217
-61,108
116,613
-63,419
Net Non Operating Interest Income Expense
2,747
3,346
4,230
523
-457
Other Income Expense
-735
3,830
-5,106
717
92
Pretax Income
-59,488
-54,041
-61,984
117,853
-63,783
Tax Provision
0
2
0
0
2
Net Income Common Stockholders
-59,489
-54,043
-61,984
117,853
-63,785
Diluted NI Available to Com Stockholders
-59,489
-54,043
-61,984
117,853
-63,785
Basic EPS
-1.70
-1.59
-1.89
3.63
-2.06
Diluted EPS
-1.70
-1.59
-1.89
3.54
-2.06
Basic Average Shares
35,033.9790
34,032.5440
32,770.6650
32,469.9570
31,005.1710
Diluted Average Shares
35,033.9790
34,032.5440
32,770.6650
33,265.5670
31,005.1710
Total Operating Income as Reported
-61,501
-61,217
-61,108
116,613
-63,418
Total Expenses
63,733
66,187
68,146
72,943
72,749
Net Income from Continuing & Discontinued Operation
-59,489
-54,043
-61,984
117,853
-63,785
Normalized Income
-58,754
-57,547.4500
-57,863.4580
117,275.0980
-63,863.2644
Interest Income
2,784
3,384
4,279
1,142
99
Interest Expense
23
25
34
605
548
Net Interest Income
2,747
3,346
4,230
523
-457
EBIT
-59,465
-54,016
-61,950
118,458
-63,235
EBITDA
-57,149
-51,647
-59,530
120,846
-60,670
Reconciled Depreciation
2,316
2,369
2,420
2,388
2,565
Net Income from Continuing Operation Net Minority Interest
-59,489
-54,043
-61,984
117,853
-63,785
Total Unusual Items Excluding Goodwill
-735
3,830
-5,106
717
92
Total Unusual Items
-735
3,830
-5,106
717
92
Normalized EBITDA
-56,414
-55,477
-54,424
120,129
-60,762
Tax Rate for Calcs
0
0.0001
0.0002
0.0002
0.0001
Tax Effect of Unusual Items
0
325.5500
-985.4580
139.0980
13.7356
12/31/2021 - 3/3/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

7UX.F Spago Nanomedical AB (publ)
0.0176
-2.22%
 
SPAGO.ST Spago Nanomedical AB (publ)
0.2120
-7.83%
 
NWRN.SW Newron Pharmaceuticals S.p.A.
7.66
-0.52%
 
2CUREX.ST 2cureX AB (publ)
5.48
+6.20%
 
IDIA.SW Idorsia Ltd
2.0250
+0.50%
 
ADXN.SW Addex Therapeutics Ltd
0.0610
+0.66%
 
SANN.SW Santhera Pharmaceuticals Holding AG
13.16
-5.05%
 
RLF.SW Relief Therapeutics Holding SA
2.1700
-1.81%
 
ADXS Ayala Pharmaceuticals, Inc.
0.0331
-1.34%
 
CUV.AX Clinuvel Pharmaceuticals Limited
10.43
+1.26%